Substance Use Disorder: Clinical Trials

2 trials for Substance Use Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2
Phase 21Completed 1

Follow Substance Use Disorder: new trials by email Literature Review of Substance Use Disorder trials Research Report on Substance Use Disorder

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
EXHIT ENTRE Comparative Effectiveness Trial
Extended Release Buprenorphine, Treatment as Usual - Substance Use Disorder, Opioid Use Disorder, Moderate
Phase 2 / Phase 3CompletedGavin Bart3442021-08-092025-12-09
Study of Icariin for Bipolar Disorder and Co-Occurring Substance Use Disorders
Icariin - Bipolar Disorder, Substance Use Disorder
Phase 3CompletedUniversity of Texas Southwestern Medical Center102013-10-012017-04-19

Narrower conditions

Substance-Related Disorders (2)  ·  Bipolar Disorder (1)  ·  Lymphoma, Follicular (1)  ·  Opioid-Related Disorders (1)

Broader conditions

Chemically-Induced Disorders (2)  ·  Mental Disorders (2)  ·  Bipolar and Related Disorders (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoproliferative Disorders (1)  ·  Mood Disorders (1)  ·  Narcotic-Related Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

Dosage Forms (1)  ·  Therapeutics (1)  ·  icariin (1)

Sponsors

Gavin Bart (1)  ·  University of Texas Southwestern Medical Center (1)

Countries

United States (2)

Top investigators

Edson S Brown, M.D., Ph.D. (1)  ·  Gavin Bart, MD,PhD (1)

Results publications

PMID 39623502

NIH funding

5UG1DA040316-05 (1)